Moreover, hepatocyte lipid deposition due to the knockout of LAPTM5 was significantly suppressed by the CDC42 knockdown, suggesting that LAPTM5 regulates the NASH progression by modulating the protein expression of CDC42 to mediate the activity of the MAPK signaling pathway. The gene discussed is CDC42; the disease is metabolic dysfunction-associated steatohepatitis.